Regulation of corticotropin releasing hormone receptor type 1 mRNA in Y-79 retinoblastoma cells
Author Information
Author(s): N. C. Vamvakopoulos, T. O. Sioutopoulou, Z. Mamuris, P. IVlarcoulatos, P. C. Avgerinos
Primary Institution: University of Thessaly Medical School
Hypothesis
The study investigates the regulation of corticotropin releasing hormone receptor type 1 mRNA in Y-79 human retinoblastoma cells by various treatments.
Conclusion
The study found that treatments with glucocorticoids, forskolin, and phorbol esters significantly stimulated the expression of corticotropin releasing hormone receptor type 1 mRNA.
Supporting Evidence
- All treatments stimulated corticotropin releasing hormone receptor type 1 gene expression relative to baseline.
- Dexamethasone was the most potent single stimulant, producing a maximal 4.5-fold increase in CRHR type 1 mRNA level.
- The Y-79 cell system expresses detectable amounts of CRH mRNA by Northern blotting.
Takeaway
Researchers looked at how certain drugs affect a specific gene in cancer cells, finding that some drugs can make the gene more active.
Methodology
The study used Y-79 human retinoblastoma cells and measured mRNA levels after treatment with various inducers.
Limitations
The study did not determine whether ligand may also regulate receptor expression in this system.
Want to read the original?
Access the complete publication on the publisher's website